Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ReCode Therapeutics
Biotech
ReCode CEO Shehnaaz Suliman eyes second half IPO opportunity
As green shoots slowly push from the biotech markets, ReCode CEO Shehnaaz Suliman, M.D., is watching closely, biding her time for a potential H2 IPO.
Annalee Armstrong
Jan 17, 2024 10:31am
Bioluminescence enters biotech venture spotlight with $477M
Nov 1, 2023 7:00am
Fierce Biotech's 2022 Fierce 15
Sep 12, 2022 3:00am
Women in biotech see Roe v. Wade ruling as a call to action
Jul 11, 2022 8:00am
ReCode breaks the mold with $120M financing, Big Pharma backing
Jun 29, 2022 6:00am
Galapagos aims to announce new CEO within weeks—Chutes & Ladders
Jan 14, 2022 9:30am
